These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 24033414

  • 1. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.
    Gelley F, Zadori G, Nemes B, Fassan M, Lendvai G, Sarvary E, Doros A, Gerlei Z, Nagy P, Schaff Z, Kiss A.
    J Gastroenterol Hepatol; 2014 Jan; 29(1):121-7. PubMed ID: 24033414
    [Abstract] [Full Text] [Related]

  • 2. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [Abstract] [Full Text] [Related]

  • 3. The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: a retrospective study.
    Vasuri F, Morelli MC, Gruppioni E, Fiorentino M, Ercolani G, Cescon M, Pinna AD, Grigioni WF, D'Errico-Grigioni A.
    Dig Liver Dis; 2013 Jun; 45(6):505-9. PubMed ID: 23317815
    [Abstract] [Full Text] [Related]

  • 4. Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7.
    Zhu B, Wei XX, Wang TB, Zhou YC, Liu AM, Zhang GW.
    Arch Virol; 2015 Aug; 160(8):2043-50. PubMed ID: 26071245
    [Abstract] [Full Text] [Related]

  • 5. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation.
    García-Reyne A, Lumbreras C, Fernández I, Colina F, Abradelo M, Magan P, San-Juan R, Manrique A, López-Medrano F, Fuertes A, Lizasoain M, Moreno E, Aguado JM.
    Transpl Infect Dis; 2013 Aug; 15(4):405-15. PubMed ID: 23725370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
    Bulfoni M, Pravisani R, Dalla E, Cesselli D, Hidaka M, Di Loreto C, Eguchi S, Baccarani U.
    J Med Virol; 2021 Aug; 93(8):4992-5000. PubMed ID: 33818800
    [Abstract] [Full Text] [Related]

  • 13. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
    Saab S, Hunt DR, Stone MA, McClune A, Tong MJ.
    Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis C virus and liver transplantation: where do we stand?
    Burra P, De Martin E, Zanetto A, Senzolo M, Russo FP, Zanus G, Fagiuoli S.
    Transpl Int; 2016 Feb; 29(2):135-52. PubMed ID: 26199060
    [Abstract] [Full Text] [Related]

  • 15. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T, Palazzo U, Ducerf C, Chevallier M, Elliott M, Baulieux J, Pouyet M, Trepo C.
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outcome and management of hepatitis C in liver transplant recipients.
    Chan SE, Rosen HR.
    Clin Infect Dis; 2003 Sep 15; 37(6):807-12. PubMed ID: 12955642
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758.
    Yang Q, Fu S, Wang J.
    Arch Virol; 2014 Nov 15; 159(11):2997-3003. PubMed ID: 25008898
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppression, liver injury and post-transplant HCV recurrence.
    Ciesek S, Wedemeyer H.
    J Viral Hepat; 2012 Jan 15; 19(1):1-8. PubMed ID: 22187942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.